Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nominations are now open for the Fierce Outsourcing Awards - Submit today
Biotech
Corcept submitted lead asset for approval despite FDA warning
Despite the FDA's warning that “significant review issues” were likely, Corcept still filed for approval and called the eventual rejection a surprise.
Darren Incorvaia
Jan 30, 2026 2:01pm
AstraZeneca returns to China's CSPC for $18.5B obesity deal
Jan 30, 2026 4:50am
Chugai drops only AI-assisted antibody from pipeline
Jan 30, 2026 10:55am
Moderna's latest CMO steps down after barely a year
Jan 30, 2026 10:58am
Amgen exits $400M autoimmune pact after running vast program
Jan 30, 2026 8:55am
CRO Sygnature Discovery plans to send 60 UK staffers packing
Jan 30, 2026 5:00pm
More News
Fierce Biotech Layoff Tracker 2026: Bitterroot, IO Biotech & more
Jan 30, 2026 3:00pm
Cardiff Oncology churns C-suite—Chutes & Ladders
Jan 30, 2026 8:30am
Moderna offloads late-stage rare disease drug for $50M upfront
Jan 30, 2026 4:14am
AI-driven Formation snaps up oral autoimmune asset in $500M play
Jan 29, 2026 1:20pm
See more stories
